• December 16, 2021
  • EFSA

Implementation of the evidence-based risk assessment for the re-evaluation of Bisphenol A: preparatory work on Mode of Action studies in mammalian, human and/or in vitro models.

Your substances


This news contains references also to other Substances

EFSA is implementing evidence‐based risk assessments for the re‐evaluation of the safety of bisphenol A (BPA) for human health. The aim of this project was to carry out preparatory tasks for the working group on BPA re‐evaluation, with particular reference to the preparation of individual summary tables from studies relating to BPA's toxicological mode of action or mechanism, and the production of a narrative and factual summary of these studies when grouped by health outcome category and by effect/endpoint.

CONTINUE READING ON www.efsa.europa.eu


Related News